Use of volatile anesthetics for sedation in the icu during the covid-19 pandemic: a national survey in france (vol’icu 2 study)

HIGHLIGHTS

SUMMARY

Consequently, physicians had to find alternatives to intravenous sedation including inhaled sedation. A previous study from the group explored inhaled sedation practices in French ICUs in 2019 and demonstrated that, even if most physicians were familiar with inhaled sedation, it was underused because of a lack of available devices, physicians knowledge, and supporting literature. Currently, recent studies have shown that inhaled sedation in COVID-19 patients reduces the need for both intravenous sedation and opïods. Several clinical trials are ongoing to study the use of inhaled sedation in ICU patients with ARDS secondary . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.